Cleveland Biolabs, Inc. Banner Image

Cleveland Biolabs, Inc.

  • Ticker CBLI
    Exchange NASDAQ More
  • Industry Research Services More
  • Sector Services More
Cleveland Biolabs, Inc. Logo Image
  • 51-200 Employees
  • Based in Buffalo, New York
Cleveland BioLabs, Inc. is a biotechnology focused on developing biodefense, tissue protection and cancer treatment drugs based on concept of modulation of cell death for therapeutic benefit. CBLI's pipeline includes products from two primary families of compounds: protectans and curaxins. It is developing protectans as drug candidates that protect healthy tissues from acute stressesMore, such as , chemotherapy and ischemia. Curaxins are being developed as anticancer agents that could act as mono-therapy drugs or in combination with other existing anticancer therapies.
4.8 / 5.0 (182)

Cleveland Biolabs, Inc. reports have an aggregate usefulness score of 4.8 based on 182 reviews.

Cleveland Biolabs, Inc.

Most Recent Annual Report

Cleveland Biolabs, Inc.
MOST RECENT 2020 Annual Report and Form 10K

Cleveland Biolabs, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Cleveland Biolabs, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!